GlobeImmune Inc. (NasdaqCM:GBIM) retained financial advisor Cantor Fitzgerald, L.P. to assist in "evaluating strategic alternatives intended to maximize shareholder value."
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -99.00% | -.--% | -.--% |
1st Jan change | Capi. | |
---|---|---|
-.--% | 5 | |
+16.73% | 121B | |
+13.04% | 107B | |
-5.80% | 24.82B | |
+1.69% | 22.48B | |
-10.09% | 18.32B | |
-40.52% | 16.33B | |
-14.00% | 15.31B | |
+1.18% | 14.08B | |
+24.18% | 11.74B |
- Stock Market
- Equities
- GBIM Stock
- News GlobeImmune, Inc.
- GlobeImmune Explores Strategic Alternatives